These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 7652221)

  • 1. [Monoclonal gammopathies of undetermined significance in the elderly: apropos of 80 cases].
    Pfitzenmeyer P; Guiguet M; d'Athis P; Maoulida I; Besancenot JF
    Rev Med Interne; 1995; 16(6):399-404. PubMed ID: 7652221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smoldering multiple myeloma.
    Cesana C; Klersy C; Barbarano L; Nosari AM; Crugnola M; Pungolino E; Gargantini L; Granata S; Valentini M; Morra E
    J Clin Oncol; 2002 Mar; 20(6):1625-34. PubMed ID: 11896113
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Impact of Serum Heavy/Light Chain Pairs in Patients With Monoclonal Gammopathy of Undetermined Significance and Smoldering Myeloma: Long-Term Results From a Single Institution.
    Magnano L; Fernández de Larrea C; Elena M; Cibeira MT; Tovar N; Aróstegui JI; Pedrosa F; Rosiñol L; Filella X; Yagüe J; Bladé J
    Clin Lymphoma Myeloma Leuk; 2016 Jun; 16(6):e71-7. PubMed ID: 27013181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical relevance and management of monoclonal gammopathy of undetermined significance and related disorders: recommendations from the European Myeloma Network.
    van de Donk NW; Palumbo A; Johnsen HE; Engelhardt M; Gay F; Gregersen H; Hajek R; Kleber M; Ludwig H; Morgan G; Musto P; Plesner T; Sezer O; Terpos E; Waage A; Zweegman S; Einsele H; Sonneveld P; Lokhorst HM;
    Haematologica; 2014 Jun; 99(6):984-96. PubMed ID: 24658815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and progression of monoclonal gammopathy of undetermined significance and light-chain MGUS in Germany.
    Eisele L; Dürig J; Hüttmann A; Dührsen U; Assert R; Bokhof B; Erbel R; Mann K; Jöckel KH; Moebus S;
    Ann Hematol; 2012 Feb; 91(2):243-8. PubMed ID: 21789623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance: a population-based study.
    Kristinsson SY; Björkholm M; Andersson TM; Eloranta S; Dickman PW; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Haematologica; 2009 Dec; 94(12):1714-20. PubMed ID: 19608666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal gammopathy of undetermined significance and risk of infections: a population-based study.
    Kristinsson SY; Tang M; Pfeiffer RM; Björkholm M; Goldin LR; Blimark C; Mellqvist UH; Wahlin A; Turesson I; Landgren O
    Haematologica; 2012 Jun; 97(6):854-8. PubMed ID: 22180421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical aspects of biclonal gammopathies. Review of 57 cases.
    Kyle RA; Robinson RA; Katzmann JA
    Am J Med; 1981 Dec; 71(6):999-1008. PubMed ID: 6797297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biclonal gammopathies: Retrospective study of 47 patients.
    García-García P; Enciso-Alvarez K; Diaz-Espada F; Vargas-Nuñez JA; Moraru M; Yebra-Bango M
    Rev Clin Esp (Barc); 2015; 215(1):18-24. PubMed ID: 25440496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monoclonal gammopathy of undetermined significance and asymptomatic multiple myelom in the year 2014 ].
    Adam Z; Krejčí M; Pour L; Sevčíková E; Křivanová A; Rehák Z; Koukalová R; Cermáková Z; Vaníček J; Sevčíková S
    Vnitr Lek; 2014 Oct; 60(10):861-79. PubMed ID: 25382009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A series of 618 cases of monoclonal gammopathies of undetermined significance: predictive factors of disappearance of monoclonal component or evolution to malignant gammopathies].
    González García ME; Fernández Alvarez C; Robles Marinas V; González Huerta AJ; Arias Miranda MI; González Rodríguez AP; García Casas J; de La Tassa JM; Fernández García J
    Rev Clin Esp; 2008 Jun; 208(6):288-94. PubMed ID: 18620653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determining the clinical significance of monoclonal gammopathy of undetermined significance: a SEER-Medicare population analysis.
    Go RS; Gundrum JD; Neuner JM
    Clin Lymphoma Myeloma Leuk; 2015 Mar; 15(3):177-186.e4. PubMed ID: 25445471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal gammopathies of undetermined significance.
    Kyle RA; Rajkumar SV
    Rev Clin Exp Hematol; 2002 Sep; 6(3):225-52. PubMed ID: 12616697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of monoclonal gammopathies and immunoglobulin levels in Japanese and United States elderly.
    Bowden M; Crawford J; Cohen HJ; Noyama O
    J Am Geriatr Soc; 1993 Jan; 41(1):11-4. PubMed ID: 8418116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of MYD88 L265P and WHIM-like CXCR4 mutation in patients with IgM monoclonal gammopathy related disease.
    Cao XX; Meng Q; Cai H; He TH; Zhang CL; Su W; Sun J; Li Y; Xu W; Zhou DB; Li J
    Ann Hematol; 2017 Jun; 96(6):971-976. PubMed ID: 28280994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation of monoclonal gammopathy of undetermined significance: a single-centre study.
    Simon Z; Sipka S; Gergely L; Csípö I; Illés A
    Clin Lab Haematol; 2006 Jun; 28(3):164-9. PubMed ID: 16706932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Features and Treatment Outcomes of Patients With Necrobiotic Xanthogranuloma Associated With Monoclonal Gammopathies.
    Higgins LS; Go RS; Dingli D; Kumar SK; Rajkumar SV; Dispenzieri A; Buadi FK; Lacy MQ; Lust JA; Kapoor P; Leung N; Lin Y; Kourelis TV; Gertz MA; Kyle RA; Gonsalves WI
    Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):447-52. PubMed ID: 27238425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Monoclonal gammopathies of undetermined significance do not systematically require a specialized consultation].
    Fouquet G; Amouzou K; Renaud L; Carpentier B; Simonnet A; Van de Wyngaert Z; Guidez S; Demarquette H; Seynave M; Deleplanque D; Yakoub-Agha I; Facon T; Leleu X
    Rev Med Interne; 2015 Jul; 36(7):444-9. PubMed ID: 25596921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up of patients with monoclonal gammopathy of undetermined significance after kidney transplantation.
    Naina HV; Harris S; Dispenzieri A; Cosio FG; Habermann TM; Stegall MD; Dean PG; Prieto M; Kyle RA; Rajkumar SV; Leung N
    Am J Nephrol; 2012; 35(4):365-71. PubMed ID: 22473253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The incidental monoclonal protein: current approach to management of monoclonal gammopathy of undetermined significance (MGUS).
    Madan S; Greipp PR
    Blood Rev; 2009 Nov; 23(6):257-65. PubMed ID: 19699016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.